GS Paper 3: Topics Covered: Developments in Science and Technology. Context: A California based pharmaceutical company has developed ARCT-154, a self-amplifying mRNA vaccine against Covid-19 infection. Benefits: It offered 95% protection against severe Covid-19 and 55% against Covid infection. What are mRNA vaccines? An mRNA vaccine use messenger RNA that encodes the …
GS Paper 3: Topics Covered: Biotechnology related issues. Context: Vaccine maker Biological E. has been selected to receive mRNA technology from the World Health Organization technology transfer hub. WHO’s technology transfer hub: Primarily set up to address the Covid-19 emergency, WHO’s technology transfer hub has the potential to expand manufacturing capacity for other products …
GS Paper 3: Topics Covered: Biotechnology related issues. Context: Data from human trials of India’s first homegrown mRNA COVID-19 vaccine are likely to be presented to authorities for evaluation by the end of the month, and company officials are aiming to roll out the product before April. The mRNA vaccine being developed by Pune-based …
GS Paper 3 Topics Covered: Biotechnology related issues. Context: Scientists attempt to turn edible plants like lettuce into mRNA vaccine factories under the edible vaccine project. The edible vaccine project: The project, backed by a US $500,000 grant from the US National Science Foundation, has three goals: Showing that DNA containing the mRNA vaccines …
